This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Asklepios Biopharmaceutical, Inc.. Active years: 2022-2024.
Company Filing History:
Years Active: 2022-2024
Title: **Innovator Spotlight: Vicci Korman**
Introduction
Vicci Korman is a notable inventor based in Minneapolis, MN, whose contributions to the field of biopharmaceuticals are marked by his innovative work on nanoparticles. With two patents to his name, Korman is recognized for his advancements in delivering therapeutic agents through sophisticated mechanisms that target cells effectively.
Latest Patents
Among Korman's latest patents is the invention of nanoparticles comprising protein-polynucleotide complexes, designed for the delivery of protein-based complexes. This invention outlines the formulation of nanoparticles that encapsulate protein-polynucleotide complexes, enabling precise delivery to target cells and intracellular locations. The therapeutic functions provided by these nanoparticles include gene editing, gene skipping induction, and regulation of gene expression. The innovative process involves synthesizing polynucleotides based on intended functions, pairing them with specific proteins, and stabilizing the resultant nanoparticle structures for enhanced therapeutic utility.
Career Highlights
Vicci Korman has established a prominent career in the biopharmaceutical sector, currently associated with Asklepios Biopharmaceutical, Inc. His expertise in developing innovative drug delivery systems reflects a significant advancement in therapeutic methodologies.
Collaborations
Korman collaborates closely with Gretchen M. Unger, a fellow innovator in the field. Their partnership highlights the importance of teamwork in driving advancements within biopharmaceutical research and development.
Conclusion
With a robust foundation in nanoparticle technology and innovative therapeutic applications, Vicci Korman continues to be a key figure in the realm of biopharmaceutical inventions. His work not only enhances drug delivery mechanisms but also opens avenues for groundbreaking treatments in gene therapy and beyond. The future looks promising as Korman pushes the boundaries of medical science through his inventive spirit.